CAS: 660847-06-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | HDAC inhibitor REF: IN-DA00FGQGCAS: 660847-06-3 | 97% | A consultar | Mar 21 Ene 25 |
 | N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-lysinamide REF: 3D-FA39438CAS: 660847-06-3 | Min. 95% | A consultar | Lun 03 Mar 25 |
Ref: IN-DA00FGQG
| 5mg | 159,00 € | ||
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-lysinamide
CAS:660847-06-3
N-Acetyl-L-leucylglycyl-N6-acetyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-lysinamide is a histone deacetylase (HDAC) inhibitor. HDAC inhibitors are used as an antiatherosclerotic and …
Pureza:
Min. 95%
Ref: 3D-FA39438
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 3 de Marzo de 2025
